Author:
Simpore J.,Pignatelli S.,Melis P.,Musumeci S.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Agarwal A, Guindo A, Cissoko Y, Taylor JG, Coulibaly D, Konè A, Kayentao K, Djinde A, Plowe CV, Doumbo O, Wellems TE, Diallo D, 2000. Hemoglobin C associated with protection from severe malaria in the Dagon of Mali, a West African population with a low prevalence of Hemoglobin S.Blood; 96 (7): 2358–2363.
2. Aluoch JR 1997. Higher resistance toPlasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Trans Med. Int. Health 2 (6): 568–71.
3. Brown AK, Sleeper LA, Miller ST, Pegelow CH, Gill FM, Waclawiw MA. 1994. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease. Arch Pediatr Adolesc Med 148(8): 796–804.
4. Chippaux JP, Massougbodji A, Castel J, Akogbeto M, Zohoun I, Zohoun T, 1992. Plasmodium falciparum or P. malariae parasitemia in carriers of sickle cell trait in various Benin biotypes.Rev Epidemiol Sante Publique; 40(4): 246–51.
5. Friedman MJ, Roth EF, Nagel RL and Trager W. 1979. The role of Hemoglobins C, S, and Nbalt in the inhibition of malaria parasite development in vitro. Am J Trop Med Hyg 28: 777–780.